BIIB logo

Biogen (BIIB) Cash From Operations

Annual CFO

$1.55 B
+$162.90 M+11.77%

December 31, 2023

Summary

Performance

1-Year Change

+11.77%

3-Year Change

-63.42%

5-Year Change

-75%

15-Year Change

-66%

BIIB Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.73%
BIIB annual cash flow from operations is higher than 96.73% of companies in Healthcare sector

High & Low

All-time High

$7.08 B
BIIB annual cash flow from operations is currently -78.14% below its historical high of $7.08 billion

3-Year Low

$1.38 B
BIIB annual cash flow from operations is currently +11.77% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BIIB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 13, 2025
BIIB next annual earnings announcement is scheduled for Feb 13, 2025

OtherBIIBcash flowmetrics:

Annual CFI

-$4.10 B
BIIB annual cash flow from investing activities is -$4.10 billion

Annual CFF

$149.30 M
BIIB annual cash flow from financing activities is $149.30 million

Annual FCF

$1.24 B
BIIB annual free cash flow is $1.24 billion

Annual CAPEX

$311.40 M
BIIB annual capital expenditures is $311.40 million

Quarterly CFO

$935.60 M
+$309.80 M+49.50%

September 30, 2024

Summary

Performance

3-Month Change

+49.5%

1-Year Change

+49.5%

3-Year Change

+49.5%

5-Year Change

+49.5%

BIIB Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.99%
BIIB quarterly cash flow from operations is higher than 97.99% of companies in Healthcare sector

High & Low

All-time High

$1.96 B
BIIB quarterly cash flow from operations is currently -52.36% below its historical high of $1.96 billion

3-Year Low

-$175.00 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BIIB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
BIIB next earnings announcement is scheduled for Feb 13, 2025

OtherBIIBcash flowmetrics:

Quarterly CFI

-$1.18 B
BIIB quarterly cash flow from investing activities is -$1.18 billion

Quarterly CFF

-$6.60 M
BIIB quarterly cash flow from financing activities is -$6.60 million

Quarterly FCF

$805.60 M
BIIB quarterly free cash flow is $805.60 million

Quarterly CAPEX

$130.00 M
BIIB quarterly capital expenditures is $130.00 million

TTM CFO

$2.13 B
+$343.20 M+19.24%

September 30, 2024

Summary

Performance

3-Month Change

+19.24%

1-Year Change

+19.24%

3-Year Change

+19.24%

5-Year Change

+19.24%

BIIB TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.64%
BIIB TTM cash flow from operations is higher than 97.64% of companies in Healthcare sector

High & Low

All-time High

$7.09 B
BIIB TTM cash flow from operations is currently -69.98% below its historical high of $7.09 billion

3-Year Low

$1.36 B
BIIB TTM cash flow from operations is currently +56.44% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BIIB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
BIIB next earnings announcement is scheduled for Feb 13, 2025

OtherBIIBcash flowmetrics:

TTM CFI

-$1.43 B
BIIB TTM cash flow from investing activities is -$1.43 billion

TTM CFF

-$1.34 B
BIIB TTM cash flow from financing activities is -$1.34 billion

TTM FCF

$1.77 B
BIIB TTM free cash flow is $1.77 billion

TTM CAPEX

$358.70 M
BIIB TTM capital expenditures is $358.70 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BIIB Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.8%+49.5%+19.2%
3 y3 years-63.4%+49.5%+19.2%
5 y5 years-75.0%+49.5%+19.2%

BIIB Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-57.5%+11.8%at high+634.6%-41.6%+56.4%
5 y5-year-78.1%+11.8%-52.3%+354.9%-70.0%+56.4%
alltimeall time-78.1%>+9999.0%-52.4%+354.9%-70.0%>+9999.0%

Biogen Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$935.60 M(+49.5%)
$2.13 B(+19.2%)
Jun 2024
-
$625.80 M(+13.1%)
$1.78 B(+8.4%)
Mar 2024
-
$553.20 M(+4325.6%)
$1.65 B(+6.3%)
Dec 2023
$1.55 B(+11.8%)
$12.50 M(-97.9%)
$1.55 B(+13.8%)
Sep 2023
-
$592.40 M(+21.6%)
$1.36 B(-4.8%)
Jun 2023
-
$487.00 M(+7.0%)
$1.43 B(-14.9%)
Mar 2023
-
$455.30 M(-360.2%)
$1.68 B(+21.2%)
Dec 2022
$1.38 B(-62.0%)
-$175.00 M(-126.5%)
$1.38 B(-42.3%)
Sep 2022
-
$661.00 M(-10.3%)
$2.40 B(-5.7%)
Jun 2022
-
$736.50 M(+355.2%)
$2.54 B(-16.2%)
Mar 2022
-
$161.80 M(-80.7%)
$3.03 B(-16.7%)
Dec 2021
$3.64 B(-13.9%)
$838.30 M(+4.1%)
$3.64 B(+49.5%)
Sep 2021
-
$805.30 M(-34.4%)
$2.43 B(-13.4%)
Jun 2021
-
$1.23 B(+59.6%)
$2.81 B(-20.4%)
Mar 2021
-
$769.00 M(-309.5%)
$3.53 B(-16.5%)
Dec 2020
$4.23 B(-40.2%)
-$367.10 M(-131.1%)
$4.23 B(-35.5%)
Sep 2020
-
$1.18 B(-39.4%)
$6.56 B(-7.3%)
Jun 2020
-
$1.95 B(+32.8%)
$7.07 B(-0.2%)
Mar 2020
-
$1.47 B(-25.1%)
$7.09 B(+0.1%)
Dec 2019
$7.08 B(+14.4%)
$1.96 B(+15.7%)
$7.08 B(+0.9%)
Sep 2019
-
$1.69 B(-13.7%)
$7.01 B(-0.6%)
Jun 2019
-
$1.96 B(+34.6%)
$7.05 B(+14.0%)
Mar 2019
-
$1.46 B(-23.0%)
$6.19 B(+0.0%)
Dec 2018
$6.19 B(+36.0%)
$1.90 B(+9.2%)
$6.19 B(+6.5%)
Sep 2018
-
$1.74 B(+57.9%)
$5.81 B(+1.9%)
Jun 2018
-
$1.10 B(-24.6%)
$5.70 B(-1.2%)
Mar 2018
-
$1.46 B(-4.0%)
$5.77 B(+26.8%)
Dec 2017
$4.55 B(-0.8%)
$1.52 B(-6.8%)
$4.55 B(-1.4%)
Sep 2017
-
$1.63 B(+39.3%)
$4.61 B(+16.0%)
Jun 2017
-
$1.17 B(+397.1%)
$3.98 B(+4.5%)
Mar 2017
-
$235.20 M(-85.1%)
$3.81 B(-17.0%)
Dec 2016
$4.59 B(+17.0%)
$1.58 B(+59.6%)
$4.59 B(+8.0%)
Sep 2016
-
$991.30 M(-0.7%)
$4.25 B(+2.3%)
Jun 2016
-
$998.20 M(-1.7%)
$4.15 B(-1.2%)
Mar 2016
-
$1.02 B(-18.3%)
$4.20 B(+7.2%)
Dec 2015
$3.92 B(+33.2%)
$1.24 B(+38.9%)
$3.92 B(+8.6%)
Sep 2015
-
$895.40 M(-14.5%)
$3.61 B(-0.5%)
Jun 2015
-
$1.05 B(+42.9%)
$3.63 B(+1.6%)
Mar 2015
-
$733.00 M(-21.4%)
$3.57 B(+21.4%)
Dec 2014
$2.94 B(+25.5%)
$932.85 M(+2.1%)
$2.94 B(+2.2%)
Sep 2014
-
$914.03 M(-7.7%)
$2.88 B(+9.2%)
Jun 2014
-
$990.59 M(+846.8%)
$2.64 B(+16.1%)
Mar 2014
-
$104.63 M(-88.0%)
$2.27 B(-3.2%)
Dec 2013
$2.35 B(+24.7%)
$869.03 M(+29.3%)
$2.35 B(+18.2%)
Sep 2013
-
$671.92 M(+7.5%)
$1.98 B(+7.0%)
Jun 2013
-
$625.21 M(+249.4%)
$1.85 B(-0.6%)
Mar 2013
-
$178.94 M(-64.8%)
$1.86 B(-0.8%)
Dec 2012
$1.88 B(+8.8%)
$507.91 M(-6.3%)
$1.88 B(+1.8%)
Sep 2012
-
$541.78 M(-14.8%)
$1.85 B(-1.5%)
Jun 2012
-
$635.58 M(+226.6%)
$1.87 B(+12.3%)
Mar 2012
-
$194.63 M(-58.9%)
$1.67 B(-3.4%)
Dec 2011
$1.73 B(+6.3%)
$473.97 M(-16.9%)
$1.73 B(+2.5%)
Sep 2011
-
$570.52 M(+32.8%)
$1.68 B(+9.2%)
Jun 2011
-
$429.67 M(+69.4%)
$1.54 B(+0.1%)
Mar 2011
-
$253.58 M(-41.2%)
$1.54 B(-5.1%)
Dec 2010
$1.62 B(+51.1%)
$431.06 M(+0.7%)
$1.62 B(+10.3%)
Sep 2010
-
$428.24 M(-0.1%)
$1.47 B(+12.4%)
Jun 2010
-
$428.48 M(+27.2%)
$1.31 B(+18.0%)
Mar 2010
-
$336.89 M(+20.6%)
$1.11 B(+3.4%)
Dec 2009
$1.07 B(-31.2%)
$279.34 M(+4.9%)
$1.07 B(-10.6%)
Sep 2009
-
$266.26 M(+16.5%)
$1.20 B(-17.0%)
Jun 2009
-
$228.55 M(-24.0%)
$1.45 B(-3.2%)
Mar 2009
-
$300.75 M(-26.2%)
$1.50 B(-4.2%)
Dec 2008
$1.56 B(+53.1%)
$407.25 M(-20.5%)
$1.56 B(+4.1%)
Sep 2008
-
$512.19 M(+85.6%)
$1.50 B(+25.2%)
Jun 2008
-
$276.02 M(-24.8%)
$1.20 B(+6.6%)
Mar 2008
-
$366.99 M(+6.1%)
$1.13 B(+10.3%)
Dec 2007
$1.02 B
$345.86 M(+64.4%)
$1.02 B(+11.4%)
Sep 2007
-
$210.43 M(+4.2%)
$916.58 M(-5.1%)
Jun 2007
-
$202.02 M(-23.0%)
$965.99 M(+2.0%)
DateAnnualQuarterlyTTM
Mar 2007
-
$262.33 M(+8.5%)
$947.34 M(+12.6%)
Dec 2006
$841.27 M(-5.4%)
$241.81 M(-6.9%)
$841.27 M(-3.8%)
Sep 2006
-
$259.84 M(+41.7%)
$874.20 M(+11.0%)
Jun 2006
-
$183.37 M(+17.4%)
$787.55 M(-5.4%)
Mar 2006
-
$156.25 M(-43.1%)
$832.87 M(-6.4%)
Dec 2005
$889.50 M(+22.2%)
$274.74 M(+58.6%)
$889.50 M(+11.8%)
Sep 2005
-
$173.19 M(-24.3%)
$795.68 M(+0.1%)
Jun 2005
-
$228.69 M(+7.4%)
$795.05 M(+8.1%)
Mar 2005
-
$212.89 M(+17.7%)
$735.34 M(+1.0%)
Dec 2004
$727.99 M(+328.3%)
$180.91 M(+4.8%)
$727.99 M(+39.5%)
Sep 2004
-
$172.56 M(+2.1%)
$521.78 M(+21.0%)
Jun 2004
-
$168.98 M(-17.8%)
$431.18 M(+44.0%)
Mar 2004
-
$205.54 M(-912.7%)
$299.46 M(+76.2%)
Dec 2003
$169.97 M(-5.2%)
-$25.29 M(-130.9%)
$169.97 M(-17.8%)
Sep 2003
-
$81.96 M(+120.0%)
$206.88 M(+8.0%)
Jun 2003
-
$37.25 M(-51.0%)
$191.62 M(-1.2%)
Mar 2003
-
$76.05 M(+554.3%)
$193.94 M(+8.2%)
Dec 2002
$179.22 M(-43.4%)
$11.62 M(-82.6%)
$179.22 M(-20.4%)
Sep 2002
-
$66.70 M(+68.6%)
$225.10 M(-8.3%)
Jun 2002
-
$39.57 M(-35.5%)
$245.49 M(-15.0%)
Mar 2002
-
$61.33 M(+6.7%)
$288.78 M(-8.8%)
Dec 2001
$316.81 M(-13.5%)
$57.50 M(-34.0%)
$316.81 M(-27.1%)
Sep 2001
-
$87.08 M(+5.1%)
$434.58 M(+2.4%)
Jun 2001
-
$82.86 M(-7.3%)
$424.48 M(-3.1%)
Mar 2001
-
$89.35 M(-49.0%)
$438.01 M(+19.5%)
Dec 2000
$366.39 M(+0.8%)
$175.28 M(+127.7%)
$366.39 M(-6.5%)
Sep 2000
-
$76.98 M(-20.1%)
$391.89 M(+1.4%)
Jun 2000
-
$96.40 M(+443.8%)
$386.31 M(+9.9%)
Mar 2000
-
$17.73 M(-91.2%)
$351.51 M(-3.3%)
Dec 1999
$363.58 M(+116.6%)
$200.78 M(+181.2%)
$363.58 M(+77.5%)
Sep 1999
-
$71.40 M(+15.9%)
$204.84 M(+7.4%)
Jun 1999
-
$61.60 M(+106.7%)
$190.75 M(+22.8%)
Mar 1999
-
$29.80 M(-29.1%)
$155.34 M(-7.4%)
Dec 1998
$167.84 M(+71.9%)
$42.05 M(-26.6%)
$167.84 M(+25.2%)
Sep 1998
-
$57.30 M(+118.7%)
$134.03 M(+5.6%)
Jun 1998
-
$26.20 M(-38.1%)
$126.93 M(-5.4%)
Mar 1998
-
$42.30 M(+413.8%)
$134.13 M(+37.4%)
Dec 1997
$97.63 M(+109.8%)
$8.23 M(-83.6%)
$97.63 M(-31.0%)
Sep 1997
-
$50.20 M(+50.3%)
$141.54 M(+39.1%)
Jun 1997
-
$33.40 M(+475.9%)
$101.74 M(+67.0%)
Mar 1997
-
$5.80 M(-88.9%)
$60.94 M(+30.9%)
Dec 1996
$46.54 M(+392.5%)
$52.14 M(+401.3%)
$46.54 M(+840.4%)
Sep 1996
-
$10.40 M(-240.5%)
$4.95 M(-225.3%)
Jun 1996
-
-$7.40 M(-14.0%)
-$3.95 M(-8163.3%)
Mar 1996
-
-$8.60 M(-181.5%)
$49.00 K(-99.5%)
Dec 1995
$9.45 M(-72.9%)
$10.55 M(+603.3%)
$9.45 M(-224.1%)
Sep 1995
-
$1.50 M(-144.1%)
-$7.61 M(-2072.5%)
Jun 1995
-
-$3.40 M(-525.0%)
$386.00 K(-80.6%)
Mar 1995
-
$800.00 K(-112.3%)
$1.99 M(-94.3%)
Dec 1994
$34.89 M(-26.7%)
-$6.51 M(-168.6%)
$34.89 M(-29.7%)
Sep 1994
-
$9.50 M(-627.8%)
$49.60 M(+1.6%)
Jun 1994
-
-$1.80 M(-105.3%)
$48.80 M(-24.5%)
Mar 1994
-
$33.70 M(+311.0%)
$64.60 M(+35.7%)
Dec 1993
$47.60 M(+10.4%)
$8.20 M(-5.7%)
$47.60 M(-29.9%)
Sep 1993
-
$8.70 M(-37.9%)
$67.90 M(-3.8%)
Jun 1993
-
$14.00 M(-16.2%)
$70.60 M(+28.4%)
Mar 1993
-
$16.70 M(-41.4%)
$55.00 M(+27.6%)
Dec 1992
$43.10 M(+630.5%)
$28.50 M(+150.0%)
$43.10 M(+136.8%)
Sep 1992
-
$11.40 M(-812.5%)
$18.20 M(+203.3%)
Jun 1992
-
-$1.60 M(-133.3%)
$6.00 M(-25.0%)
Mar 1992
-
$4.80 M(+33.3%)
$8.00 M(+35.6%)
Dec 1991
$5.90 M(-44.9%)
$3.60 M(-550.0%)
$5.90 M(-1.7%)
Sep 1991
-
-$800.00 K(-300.0%)
$6.00 M(-36.2%)
Jun 1991
-
$400.00 K(-85.2%)
$9.40 M(-37.7%)
Mar 1991
-
$2.70 M(-27.0%)
$15.10 M(+41.1%)
Dec 1990
$10.70 M(-242.7%)
$3.70 M(+42.3%)
$10.70 M(+52.9%)
Sep 1990
-
$2.60 M(-57.4%)
$7.00 M(+59.1%)
Jun 1990
-
$6.10 M(-458.8%)
$4.40 M(-358.8%)
Mar 1990
-
-$1.70 M
-$1.70 M
Dec 1989
-$7.50 M
-
-

FAQ

  • What is Biogen annual cash flow from operations?
  • What is the all time high annual CFO for Biogen?
  • What is Biogen annual CFO year-on-year change?
  • What is Biogen quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Biogen?
  • What is Biogen quarterly CFO year-on-year change?
  • What is Biogen TTM cash flow from operations?
  • What is the all time high TTM CFO for Biogen?
  • What is Biogen TTM CFO year-on-year change?

What is Biogen annual cash flow from operations?

The current annual CFO of BIIB is $1.55 B

What is the all time high annual CFO for Biogen?

Biogen all-time high annual cash flow from operations is $7.08 B

What is Biogen annual CFO year-on-year change?

Over the past year, BIIB annual cash flow from operations has changed by +$162.90 M (+11.77%)

What is Biogen quarterly cash flow from operations?

The current quarterly CFO of BIIB is $935.60 M

What is the all time high quarterly CFO for Biogen?

Biogen all-time high quarterly cash flow from operations is $1.96 B

What is Biogen quarterly CFO year-on-year change?

Over the past year, BIIB quarterly cash flow from operations has changed by +$309.80 M (+49.50%)

What is Biogen TTM cash flow from operations?

The current TTM CFO of BIIB is $2.13 B

What is the all time high TTM CFO for Biogen?

Biogen all-time high TTM cash flow from operations is $7.09 B

What is Biogen TTM CFO year-on-year change?

Over the past year, BIIB TTM cash flow from operations has changed by +$343.20 M (+19.24%)